The effect of transcutaneous auricular vagus nerve stimulation on tourniquet-induced hypertension

Application of transauricular vagus nerve stimulation in perioperative period

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100052558

Enrollment

Unknown

Registered

2021-10-31

Start date

2021-11-02

Completion date

Unknown

Last updated

2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

perioperative cardiovascular event

Interventions

Transcutaneous auricular vagus nerve group:Transcutaneous auricular vagus nerve

Sham stimulation group:Sham stimulation

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. AmericanSociety of Anesthesia (ASA) I-II; 2. Aged from 18 to 60 years undergoing orthopedic surgery.

Exclusion criteria

Exclusion criteria: 1. Participants with hypertension; 2. Severe cardiovascular and pulmonary diseases participants; 3. Participants with diabetes and autonomic nervous diseases; 4. Participants which researchers believes not suitable for selection.

Design outcomes

Primary

Measure	Time frame
Perioperative hemodynamics;	—

Secondary

Measure	Time frame
Perioperative drug use;Complications after surgery;	—

Countries

China

Contacts

Public ContactWang Qiujun

The Third Hospital of Hebei Medical University

wangqiujunsy@163.com+86 18533112929

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026